Invesco DB Commodity Index Tracking Fund vs Herbalife Nutrition Ltd — how do they compare? Invesco DB Commodity Index Tracking Fund trades at $33.08 (market cap $1.92B), while Herbalife Nutrition Ltd trades at $12.78 (market cap $1.34B). The key difference: Invesco DB Commodity Index Tracking Fund is the larger of the two by market cap, and Invesco DB Commodity Index Tracking Fund is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco DB Commodity Index Tracking Fund for 61 Days and Herbalife Nutrition Ltd for 43 Days on average.
| DBC | HLF | |
|---|---|---|
Market Cap | $1.92B | $1.34B |
Volume | 1,375,556 | 1,589,457 |
Sector | Commodities - Metals/Agriculture | Consumer Staples |
52-Week High | $33.68 | $19.96 |
52-Week Low | $22.07 | $7.75 |
Typical Hold Time | 61 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
DBC trades at $32.51, down 0.55% today, with a bullish technical signal from moving averages. The company reported $82.59M revenue and $22.38M net income for 2024, showing improved profitability with a 27.1% margin. Cash flow from operations was strong at $431.54M, though total assets declined from $2.7B in 2021 to $1.29B currently. Technical indicators show support at $32 and resistance at $33.
DBC demonstrates solid operational cash generation despite asset base contraction. The zero-debt balance sheet provides financial stability, but declining revenue from 2023's $108M raises growth concerns. Current valuation metrics remain undisclosed, requiring deeper analysis. The stock's technical strength suggests near-term upside potential if fundamental performance stabilizes.
HLF trades at $12.65, up 0.56% today, with a bullish technical signal from moving averages. The stock shows attractive valuation with a P/E of 8.22 and P/S of 0.26. Recent earnings were mixed, with a Q1 2026 beat but Q4 2025 and Q2 2026 misses. The company announced a $250 million share repurchase program and a CEO transition effective October 31, 2026. Cash flow trends show improvement, with 2026 projected net cash flow turning positive at $50 million.
The outlook is cautiously optimistic, supported by analyst consensus price target of $19.00 implying significant upside. Key opportunities include debt reduction progress and margin expansion plans. Risks include inconsistent earnings performance, high debt levels, and investor scrutiny following the CEO transition. The stock remains a value play if execution improves.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
DBC is a diversified commodity ETF that tracks the DBIQ Optimum Yield Diversified Commodity Index. It invests in futures contracts for 14 heavily traded commodities, including crude oil, gold, and corn, while optimizing for yield and roll costs.
Read more on DBC →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →